{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:40:49Z","timestamp":1790995249730,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1245\/aso.2004.03.019","type":"journal-article","created":{"date-parts":[[2004,2,4]],"date-time":"2004-02-04T23:27:51Z","timestamp":1075937271000},"page":"173-177","source":"Crossref","is-referenced-by-count":58,"title":["Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-\u03b1 and Melphalan for Bulky In-Transit Melanoma Metastases"],"prefix":"10.1245","volume":"11","author":[{"given":"Carlo Riccardo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirto","family":"Foletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"173_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10434-999-0315-x","volume":"6","author":"PJ Borgstein","year":"1999","unstructured":"Borgstein PJ, Meijer S, van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable?. Ann Surg Oncol 1999;6:315\u2013321.","journal-title":"Ann Surg Oncol"},{"key":"173_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.2930440305","volume":"44","author":"JH Wong","year":"1990","unstructured":"Wong JH, Cagle LA, Kopald KH, Swisher SG, Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol 1990;44:146\u2013150.","journal-title":"J Surg Oncol"},{"key":"173_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0011-3840(99)80008-2","volume":"36","author":"DL Fraker","year":"1999","unstructured":"Fraker DL. Hyperthermic regional perfusion for melanoma and sarcoma of the limbs. Curr Probl Surg 1999;36:841\u2013907.","journal-title":"Curr Probl Surg"},{"key":"173_CR4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/sonc.2002.34119","volume":"29","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Pilati P, Mocellin S, Lise M. Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 2002;29:400\u2013409.","journal-title":"Semin Oncol"},{"key":"173_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archsurg.1996.01430140110029","volume":"131","author":"RE Allen Jr.","year":"1996","unstructured":"Allen RE Jr. Systemic leakage and side effects of tumor necrosis factor alpha administration via isolated limb perfusion can be manipulated by flow rate adjustment. Arch Surg 1996;131:220.","journal-title":"Arch Surg"},{"key":"173_CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jso.10077","volume":"79","author":"BB Kroon","year":"2002","unstructured":"Kroon BB, Noorda EM, Vrouenraets BC, Nieweg OE. Isolated limb perfusion for melanoma. J Surg Oncol 2002;79:252\u2013255.","journal-title":"J Surg Oncol"},{"key":"173_CR7","unstructured":"Steinmann G. An open, randomized prospective trial to compare the efficacy and safety of TNFalpha 1a and melphalan with melphalan alone via isolated limb perfusion for metastatic melanoma of the limb. In: Christine Clark, ed. Beromun, Second Expert Meeting. Barcelona, 2001:16\u201318."},{"key":"173_CR8","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1007\/BF02640542","volume":"9","author":"D Fraker","year":"2002","unstructured":"Fraker D, Alexander H, Ross M, et al. A phase III trial of isolated limb perfusion for extremity melanoma comparing melphalan alone versus melphalan plus tumor necrosis factor (TNF) plus interferon gamma (IFN). Ann Surg Oncol 2002;9:S8.","journal-title":"Ann Surg Oncol"},{"key":"173_CR9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/bjs.1800800820","volume":"80","author":"S Hill","year":"1993","unstructured":"Hill S, Fawcett WJ, Sheldon J, Soni N, Williams T, Thomas JM. Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion. Br J Surg 1993;80:995\u2013997.","journal-title":"Br J Surg"},{"key":"173_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00002371-199909000-00004","volume":"22","author":"F Di Filippo","year":"1999","unstructured":"Di Filippo F, Rossi CR, Vaglini M, et al. Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study. J Immunother 1999;22:407\u2013414.","journal-title":"J Immunother"},{"key":"173_CR11","first-page":"305","volume":"129","author":"JS Stehlin Jr.","year":"1969","unstructured":"Stehlin JS Jr. Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 1969;129:305\u2013308.","journal-title":"Surg Gynecol Obstet"},{"key":"173_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archsurg.1974.01360020164032","volume":"109","author":"CM McBride","year":"1974","unstructured":"McBride CM. Sarcomas of the limbs. Results of adjuvant chemotherapy using isolation perfusion. Arch Surg 1974;109:304\u2013308.","journal-title":"Arch Surg"},{"key":"173_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(197601)37:1<188::AID-CNCR2820370127>3.0.CO;2-S","volume":"37","author":"EV Sugarbaker","year":"1976","unstructured":"Sugarbaker EV, McBride CM. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities. Cancer 1976;37:188\u2013198.","journal-title":"Cancer"},{"key":"173_CR14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1177\/030089160208800351","volume":"88","author":"D Casara","year":"2002","unstructured":"Casara D, Rubello D, Pilati PL, Scalerta R, Foletto M, Rossi CR. A simplified procedure for continuous intraoperative external monitoring of systemic leakage during isolated limb perfusion. Tumori 2002;88:S61\u20133.","journal-title":"Tumori"},{"key":"173_CR15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthuis GA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 1982;18:905\u2013910.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"173_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00008390-199910000-00009","volume":"9","author":"D Lienard","year":"1999","unstructured":"Lienard D, Eggermont AM, Koops HS, et al. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study. Melanoma Res 1999;9:491\u2013502.","journal-title":"Melanoma Res"},{"key":"173_CR17","first-page":"107","volume":"7","author":"MG Rosenblum","year":"1988","unstructured":"Rosenblum MG, Donato NJ, Gutterman JU. Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in culture. Lymphokine Res 1988;7:107\u2013117.","journal-title":"Lymphokine Res"},{"key":"173_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02303797","volume":"4","author":"JF Buell","year":"1997","unstructured":"Buell JF, Reed E, Lee KB, et al. Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells. Ann Surg Oncol 1997;4:141\u2013148.","journal-title":"Ann Surg Oncol"},{"key":"173_CR19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1054\/bjoc.1999.1032","volume":"82","author":"JH de Wilt","year":"2000","unstructured":"de Wilt JH, ten Hagen TL, de Boeck G, van Tiel ST, de Bruijn EA, Eggermont AM. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion. Br J Cancer 2000;82:1000\u20131003.","journal-title":"Br J Cancer"},{"key":"173_CR20","first-page":"55","volume":"89","author":"HI Robins","year":"1995","unstructured":"Robins HI, d\u2019Oleire F, Kutz M, et al. Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia. Cancer Lett 1995;89:55\u201362.","journal-title":"Cancer Lett"},{"key":"173_CR21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1054\/bjoc.1999.1027","volume":"82","author":"AH van der Veen","year":"2000","unstructured":"van der Veen AH, Wilt JH de, Eggermont AM, Tiel ST van, Seynhaeve AL, ten Hagen TL. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects. Br J Cancer 2000;82:973\u2013980.","journal-title":"Br J Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.03.019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/ASO.2004.03.019\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.03.019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T10:44:06Z","timestamp":1585565046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/ASO.2004.03.019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1245\/aso.2004.03.019","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}